Retinoids in cancer chemoprevention. Clinical trials with the synthetic analogue fenretinide.
Istituto Nazionale Tumori, Milan, Italy.
A
A
Costa
G
G
De Palo
A
A
Decensi
F
F
Formelli
F
F
Chiesa
M
M
Nava
T
T
Camerini
E
E
Marubini
U
U
Veronesi
D016588:Anticarcinogenic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D002280:Basal Cell Carcinoma / Q000517:prevention & control*; D002454:Cell Differentiation; D002455:Cell Division; D002986:Clinical Trials as Topic; D005260:Female; D017313:Fenretinide / Q000009:adverse effects / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D007972:Leukoplakia, Oral / Q000517:prevention & control*; D008954:Models, Biological; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D001749:Urinary Bladder Neoplasms / Q000517:prevention & control*
D016588:Anticarcinogenic Agents; D017313:Fenretinide